Cachexia Pipeline Analysis 2018 – Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Developments.Cachexia Pipeline Analysis report covers 21 drugs currently in different phases of development. Cachexia or muscle wasting is a condition characterised by extreme weight loss and muscle wasting including body fat. It generally affects the people with serious disease such as cancer, HIV, ESRD etc. the loss or wastage may occur due to reasons such as change i Read more...
Autoimmune Hepatitis Pipeline Analysis report covers drugs of 7 companies currently in different phases of development. Autoimmune hepatitis is a long-lasting disease in which the body’s immune system fights against the normal liver cells instead of fighting against bacteria, viruses or other foreign substances. This gives rise to the liver inflammation leading to liver damage and failure. If diagnosed early, autoimmune hepatitis can be treated via immunosuppressive drugs. The exact cause of t Read more...
Alport Syndrome Pipeline Analysis report covers more than 5 drugs currently in different phases of development. Alport Syndrome is an inherited disorder involving the glomerular basement membrane of the kidney. The disease is characterized by loss of kidney function, hearing loss, and ophthalmic disorders. Symptoms of the disease are hematuria, nep Read more...
Alagille Syndrome Pipeline Analysis report covers therapies which include companies and research organizations or institutes, in total 4 in number currently in different phases of development. Alagille syndrome (ALGS) is a genetic disorder which occurs due to the mutations caused in either of the JAG1 or NOTCH2 gene. The genes instruct in making pr Read more...
Adrenoleukodystrophy is a rare genetic disorder characterised by loss or damage of myelin sheath surrounding and insulating the nerve cells. The damage of the myelin sheath further leads to the progressive loss of the fuctioning of the adrenal glands. Symptoms of adrenoleukodystrophy are muscle spasms and pain, impaired vision, trouble balancing the body, deterioration of motor control, Adrenal insufficiency and lethargy and clumsiness. Diagnosis is done using blood tests, Skin biopsy and fibr Read more...
Hairy cell leukemia Pipeline Analysis 2018 – Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Developments.Hairy cell leukemia Pipeline Analysis report covers drugs of 8 companies currently in different phases of development. Hairy cell leukemia is a rare type of white blood cells cancer where the bone marrow makes too many lymphocytes (B cells). B cells is one of the types of white blood cells which fight against infection. The excess B cells appear Read more...
Meningioma Pipeline Analysis 2018 – Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Developments.Meningioma Pipeline Analysis report covers 13 drugs currently in different phases of development. Meningioma is the tumor that develops in the layer called meninges which protect the brain and spinal cord. These are the most common form of tumors, slow growing and are mostly benign. When small in size meningioma may not cause any symptoms, however, larger Read more...
Transthyretin (TTR) Related Amyeloidosis (ATTR) Pipeline Analysis 2018 – Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Developments.Transthyretin (TTR) Related Amyeloidosis Pipeline Analysis report covers 11 drugs currently in different phases of development. Transthyretin (TTR) Related Amyeloidosis or ATTR is a rare, progressive condition characterized by abnormal buildup of amyloid protein in different tissues and organs of the body. The disease Read more...
Familial Partial Lipodystrophy (FPLD) Pipeline Analysis report covers 3 drugs currently in different phases of development. FPLD is a rare, genetic condition characterized by the abnormal fat distribution in the body. Adipose tissue surrounding the internal organs and just beneath the skin is responsible for storing the fat. In people with FPLD adi Read more...
Homozygous Familial Hypercholesterolemia (HoFH) Pipeline Analysis report covers 7 drugs currently in different phases of development. HoFH is an inherited rare disorder characterised by difficult lipoprotein metabolism and extremely high level of circulating low density lipoprotein cholesterol (ranging between 500 and 1200 mg/dl.). These high level of cholesterol accumulates in the arteries leading to cardiovascular disease much faster than in the normal population. The disease is caused due t Read more...
.jpg)
